BioMarin Pharmaceutical filed a report with the Securities and Exchange Commission on July 24, 2026.
3 reports, 1 independent
Updated Aug 18
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioMarin Pharmaceutical filed a report with the Securities and Exchange Commission on July 24, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
BioMarin Pharmaceutical
American company
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- TG Therapeutics filed reports with the Securities and Exchange Commission on June 28, 2026.
- Alterity Therapeutics Limited disclosed corporate transactions with the Securities and Exchange Commission on September 1, 2026.
- Applied DNA Sciences and BioMarin Pharmaceutical are identified as competing companies within the healthcare market.
- Century Communities filed a report with the Securities and Exchange Commission on August 27, 2026.
- Bristol-Myers Squibb filed Form 13F with the Securities and Exchange Commission on August 25, 2026.